Galvanize Therapeutics aims to become the global leader in delivering medical technology innovations that drive biologic processes to treat a range of diseases, starting with treating chronic bronchitis symptoms, cardiac arrhythmias, and solid tumors. Formed by ATP (Apple Tree Partners) in 2022, Galvanize has its headquarters in San Carlos, Calif., and is researching and commercializing its revolutionary AliyaTM Pulsed Electric Field (PEF) energy platform in the United States and Europe.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/15/22 | $100,000,000 | Series B |
ATP Fund Fidelity Management & Research Company  Gilmartin Capital Intuitive Surgical | undisclosed |
